Dasminapant (SM-1387) is an inhibitor of apoptosis proteins antagonist that promotes rapid degradation of cIAP1/2 and XIAP, exhibiting pronounced antitumor effects against nasopharyngeal carcinoma stem cells and synergistically enhancing chemosensitivity and apoptosis when combined with cisplatin and 5-fluorouracil in both in vitro and in vivo models.
Molecular Weight:
1157.41
CAS Number:
[1570231-89-8]
Formula:
C60H72N10O10S2
Target:
IAP
T30095
T30095
* VAT and and shipping costs not included. Errors and price changes excepted